Products - Sarcoma | Topic | NICE

Showing 3 products

Date | Title

Status: Awaiting developmentRemove ‘Status: Awaiting development’ filter

Selinexor for treating unresectable dedifferentiated advanced liposarcoma [ID3825]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Afamitresgene autoleucel for previously treated MAGE-A4 positive advanced synovial sarcoma or myxoid round cell liposarcoma [ID4064]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Letetresgene autoleucel for treating NY-ESO-1 advanced unresectable synovial sarcoma in people aged 10 and over or NY-ESO-1 advanced unresectable myxoid round cell liposarcoma in adults TS ID 10652
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC